Buying Kindred | Humana

Beyond the Hospital: Why Humana’s Full Acquisition of Kindred at Home Matters

The acquisition of Kindred at Home (KAH) by Humana was a multi-year strategic process that concluded in 2021, marking a significant shift toward integrated, home-based care. Humana first purchased a 40% stake in the company for $800 million in 2018 through a joint venture with private equity firms TPG Capital and Welsh, Carson, Anderson & Stowe. In August 2021, Humana fully acquired the remaining 60% for approximately $5.7 billion, making Kindred at Home a wholly owned subsidiary. humana buying kindred

Kindred at Home brought a massive infrastructure of 43,000 clinicians serving over 550,000 patients annually. For Humana, the primary driver was the ability to manage complex, high-risk patient populations —particularly those with chronic comorbidities who are significantly more likely to face frequent hospitalizations. Inside the Kindred Deal…and Why It Makes Sense Beyond the Hospital: Why Humana’s Full Acquisition of

Humana’s path to ownership was methodical. Starting with a 40% minority stake in 2018, the insurer spent three years integrating Kindred’s clinical expertise into its value-based care ecosystem before buying the remaining interest in 2021. This allowed Humana to scale its capabilities gradually, eventually creating the nation's largest home health provider. Kindred at Home brought a massive infrastructure of

The healthcare landscape is shifting from clinical corridors to the comfort of the living room. Humana’s completion of its Kindred at Home acquisition isn't just a corporate merger; it’s a full-scale commitment to a "home-first" care model that aims to improve patient outcomes while lowering costs.